Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$452M |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$359M |
| 3 |
Accenture
ACN
|
+$329M |
| 4 |
Becton Dickinson
BDX
|
+$318M |
| 5 |
Coca-Cola
KO
|
+$269M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$517M |
| 2 |
Chevron
CVX
|
+$454M |
| 3 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$429M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$355M |
| 5 |
Dollar Tree
DLTR
|
+$348M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.79% |
| 2 | Financials | 11.74% |
| 3 | Healthcare | 10.79% |
| 4 | Consumer Discretionary | 8.84% |
| 5 | Industrials | 8.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RUBY
3051
DELISTED
Rubius Therapeutics, Inc
RUBY
| $1.3M | ﹤0.01% |
53,261
+4,838
| +10% | +$121K |
|
|
TEI
3052
Templeton Emerging Markets Income Fund
TEI
$320M
| $1.3M | ﹤0.01% |
162,590
+5,461
| +3% | +$42.6K |
|
|
KYNB
3053
Kyntra Bio
KYNB
$28.7M
| $1.29M | ﹤0.01% |
1,946
-789
| -29% | -$455K |
|
3054
Invesco Dorsey Wright Consumer Staples Momentum ETF
PSL
$83.4M
| $1.29M | ﹤0.01% |
13,818
+278
| +2% | +$26.3K |
|
3055
ALPS Medical Breakthroughs ETF
SBIO
$217M
| $1.29M | ﹤0.01% |
26,438
+1,098
| +4% | +$52.6K |
|
3056
BlackRock Enhanced Captial and Income Fund
CII
$1.01B
| $1.29M | ﹤0.01% |
62,743
-802
| -1% | -$16.3K |
|
3057
Anfield Universal Fixed Income ETF
AFIF
$228M
| $1.29M | ﹤0.01% |
132,298
| – | – |
|
3058
iShares Global Healthcare ETF
IXJ
$4.23B
| $1.29M | ﹤0.01% |
15,473
-8,976
| -37% | -$726K |
|
3059
First Trust Nasdaq Artificial Intelligence and Robotics ETF
ROBT
$780M
| $1.28M | ﹤0.01% |
23,654
-3,719
| -14% | -$197K |
|
3060
Teva Pharmaceuticals
TEVA
$42.8B
| $1.28M | ﹤0.01% |
129,603
-101,621
| -44% | -$1.08M |
|
|
LBAI
3061
DELISTED
Lakeland Bancorp Inc
LBAI
| $1.28M | ﹤0.01% |
73,157
-5,218
| -7% | -$94.6K |
|
3062
Neuronetics
STIM
$223M
| $1.27M | ﹤0.01% |
79,484
-4,400
| -5% | -$60.8K |
|
3063
Timothy Plan High Dividend Stock ETF
TPHD
$369M
| $1.27M | ﹤0.01% |
42,355
+2,907
| +7% | +$87.4K |
|
3064
Credit Acceptance
CACC
$5.99B
| $1.26M | ﹤0.01% |
2,777
-151
| -5% | -$61.9K |
|
3065
Cars.com
CARS
$648M
| $1.26M | ﹤0.01% |
+87,862
| New | +$1.22M |
|
3066
Pembina Pipeline
PBA
$28.4B
| $1.26M | ﹤0.01% |
39,549
-3,507
| -8% | -$110K |
|
|
KBAL
3067
DELISTED
Kimball International
KBAL
| $1.25M | ﹤0.01% |
94,866
-18,725
| -16% | -$255K |
|
3068
Select Water Solutions
WTTR
$2.73B
| $1.25M | ﹤0.01% |
206,532
+31,087
| +18% | +$179K |
|
3069
WisdomTree US High Dividend Fund
DHS
$1.58B
| $1.25M | ﹤0.01% |
15,933
-222
| -1% | -$17.5K |
|
3070
Invesco Pharmaceuticals ETF
PJP
$499M
| $1.25M | ﹤0.01% |
15,369
+3
| +0% | +$238 |
|
3071
RPC Inc
RES
$1.4B
| $1.25M | ﹤0.01% |
251,306
-3,873
| -2% | -$20.9K |
|
3072
1st Source
SRCE
$2.13B
| $1.24M | ﹤0.01% |
26,778
+34
| +0.1% | +$1.63K |
|
3073
Financial Institutions
FISI
$825M
| $1.24M | ﹤0.01% |
41,263
-2,897
| -7% | -$90.5K |
|
|
VIOT
3074
Viomi Technology
VIOT
$48M
| $1.23M | ﹤0.01% |
145,123
+15,305
| +12% | +$124K |
|
3075
MidCap Financial Investment
MFIC
$795M
| $1.23M | ﹤0.01% |
90,150
+21,549
| +31% | +$309K |
|
Similar funds
Ameriprise's Q2 2021 Portfolio in Review
As of Q2 2021, Ameriprise held 4,059 positions worth $323B, up 7.5% from $301B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Ameriprise's Q2 2021 filing shows 217 new, 1,726 increased, 1,816 reduced and 179 closed positions. Its largest new stake was NiSource Inc. Series A Corporate Units: 830,300 shares worth $85.5M. The largest sale was UnitedHealth, an estimated $517M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- Ameriprise's largest Q2 2021 buy was NiSource Inc. Series A Corporate Units: 830,300 shares worth $85.5M.
- Ameriprise added most to ExxonMobil in Q2 2021, an estimated $452M increase.
- Ameriprise's biggest Q2 2021 reduction was UnitedHealth, cutting an estimated $517M.
- Ameriprise fully exited INPHI CORPORATION in Q2 2021, selling an estimated $139M.
- Ameriprise's ten largest holdings make up 15% of its $323B portfolio in Q2 2021.
- Ameriprise opened 217 new positions and closed 179 in Q2 2021.
- Ameriprise's portfolio value rose 7.5% quarter-over-quarter to $323B.
Based on Ameriprise's 13F filing for Q2 2021, filed 16 Aug 2021.